Kanamycin antisense nucleic acid for the treatment of cancer

• 收藏
• 分享

专利权人:

Rose Ann Padua

发明人:

Rose Ann Padua,Christine Chomienne

申请号：

US13258173

公开号：

US09029135B2

申请日:

2010.03.26

申请国别(地区):

US

年份:

2015

代理人:

摘要：

The invention relates to a nucleic acid comprising a sequence complementary to a fragment of the sequence coding for the kanamycin resistance protein. This nucleic acid is useful as a DNA vaccine adjuvant, and can be used e.g. for treating cancer, for example in combination with a non-immunosuppressive inducer of tumor cell apoptosis such as all-trans retinoic acid (ATRA).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/